Choice of antifibrotic medication and disease severity predict weight loss in idiopathic pulmonary fibrosis

A Perelas, J Glennie, K van Kerkhove, M Li… - Pulmonary …, 2019 - Elsevier
Purpose Although safety and tolerability of approved antifibrotics has been reported
extensively, little is known about their effects on weight. We analyzed predictors of weight …
被引用次数：13 相关文章

[引用][C] Choice of antifibrotic medication and disease severity predict weight loss in idiopathic pulmonary fibrosis

A Perelas, J Glennie, K van Kerkhove, M Li… - Pulmonary …, 2019 - cir.nii.ac.jp
Choice of antifibrotic medication and disease severity predict weight loss in idiopathic
pulmonary fibrosis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
[PDF] researchgate.net

[PDF][PDF] Choice of antifibrotic medication and disease severity predict weight loss in idiopathic pulmonary fibrosis

A Perelas, J Glennie, K van Kerkhove, M Li… - Pulm Pharmacol …, 2019 - researchgate.net
Purpose: Although safety and tolerability of approved antifibrotics has been reported
extensively, little is known about their effects on weight. We analyzed predictors of weight …

Choice of antifibrotic medication and disease severity predict weight loss in idiopathic pulmonary fibrosis.

A Perelas, J Glennie, K van Kerkhove, M Li… - Pulmonary …, 2019 - europepmc.org
Purpose Although safety and tolerability of approved antifibrotics has been reported
extensively, little is known about their effects on weight. We analyzed predictors of weight …

Choice of antifibrotic medication and disease severity predict weight loss in idiopathic pulmonary fibrosis

A Perelas, J Glennie… - Pulmonary …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose Although safety and tolerability of approved antifibrotics has been reported
extensively, little is known about their effects on weight. We analyzed predictors of weight …
[HTML] nih.gov

[HTML][HTML] Choice of antifibrotic medication and disease severity predict weight loss in idiopathic pulmonary fibrosis

A Perelas, J Glennie, K van Kerkhove, M Li… - Pulmonary …, 2019 - ncbi.nlm.nih.gov
Purpose: Although safety and tolerability of approved antifibrotics has been reported
extensively, little is known about their effects on weight. We analyzed predictors of weight …